期刊
CANCER JOURNAL
卷 22, 期 4, 页码 296-301出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PPO.0000000000000201
关键词
Hepatocellular carcinoma; radiotherapy; SBRT
类别
Hepatocellular carcinoma (HCC) is a leading cause of cancer death. Experience with radiotherapy for HCC is increasing. Stereotactic body radiotherapy allows the delivery of tumoricidal doses in 3 to 6 treatments to focal HCC with low rates of toxicity and excellent local control. Stereotactic body radiotherapy can be used to control disease in patients unsuitable for other conventional therapies. How it might optimally be used to improve outcomes, including its use in combination with other therapies, is an area of active research, and further randomized studies are needed. This review discusses the current literature and possible future treatment and research opportunities.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据